{"filing":{"accession_number":"0001213900-26-063531","cik":"0001506251","ticker":"CTXR","company_name":"Citius Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-01","report_date":null,"primary_document":"ea0292904-8k_citius.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026063531/ea0292904-8k_citius.htm"},"events":[{"id":7863,"run_id":6899,"accession_number":"0001213900-26-063531","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"summary":"The disclosure announces presentation of clinical data at the American Society of Clinical Oncology Annual Meeting by the company's wholly-owned subsidiary Citius Oncology. While clinical data presentations can be material to investors evaluating pipeline progress and competitive positioning, the filing does not specify the nature, significance, or outcomes of the data presented. Without details on efficacy, safety, or regulatory implications, this is best classified as other_material rather than a more specific event type.","company_name":"Citius Pharmaceuticals, Inc.","ticker":"CTXR","filing_date":"2026-06-01","form":"8-K","submitted_at":null,"items":[{"id":3238,"accession_number":"0001213900-26-063531","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"The disclosure announces presentation of clinical data at the American Society of Clinical Oncology Annual Meeting by the company's wholly-owned subsidiary Citius Oncology. While clinical data presentations can be material to investors evaluating pipeline progress and competitive positioning, the filing does not specify the nature, significance, or outcomes of the data presented. Without details on efficacy, safety, or regulatory implications, this is best classified as other_material rather than a more specific event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:45:36.734305+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3238,"accession_number":"0001213900-26-063531","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"The disclosure announces presentation of clinical data at the American Society of Clinical Oncology Annual Meeting by the company's wholly-owned subsidiary Citius Oncology. While clinical data presentations can be material to investors evaluating pipeline progress and competitive positioning, the filing does not specify the nature, significance, or outcomes of the data presented. Without details on efficacy, safety, or regulatory implications, this is best classified as other_material rather than a more specific event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:45:36.734305+00:00","company_name":"Citius Pharmaceuticals, Inc.","ticker":"CTXR","filing_date":"2026-06-01"}]}